DiaMedica Therapeutics Ownership | Who Owns DiaMedica Therapeutics?

Overview ForecastFinancials Chart Transcripts

DiaMedica Therapeutics Ownership Summary

DiaMedica Therapeutics is owned by 17.54% institutional investors, 15.65% insiders, and 66.82% retail investors. Cooperman leon g is the largest institutional shareholder, holding 3.80% of DMAC shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.00% of its assets in DiaMedica Therapeutics shares.

DMAC Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	DiaMedica Therapeutics	17.54%	15.65%	66.82%
Sector	Healthcare Stocks	279.15%	10.63%	-189.78%
Industry	Biotech Stocks	63.94%	10.67%	25.38%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Cooperman leon g	1.63M	3.80%	$8.82M
Vanguard group	1.24M	2.91%	$6.74M
First manhattan co. llc.	839.08K	1.96%	$4.56M
Paragon associates & paragon associates ii joint venture	514.78K	1.20%	$2.80M
Bleichroeder lp	382.32K	0.89%	$2.08M
Susquehanna group, llp	374.85K	0.88%	$2.04M
Geode capital management	305.75K	0.72%	$1.66M
Lpl financial	152.00K	0.36%	$825.36K
Northern trust	120.39K	0.32%	$355.15K
Blackrock	105.30K	0.28%	$310.64K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Paragon associates & paragon associates ii joint venture	514.78K	6.46%	$2.80M
Bleichroeder lp	382.32K	0.52%	$2.08M
Cooperman leon g	1.63M	0.33%	$8.82M
Catalyst financial partners	38.46K	0.04%	$208.82K
Magnolia capital advisors	10.16K	0.03%	$55.17M
First manhattan co. llc.	839.08K	0.01%	$4.56M
Stonebridge capital advisors	17.50K	0.01%	$95.03K
Naples money management	2.98K	0.01%	$8.79K
Meridian wealth management	27.22K	0.01%	$147.78K
Y-intercept (hong kong)	14.97K	0.01%	$81.30K

Top Buyers

Holder	Shares	% Assets	Change
Susquehanna group, llp	374.85K	0.00%	273.39K
Vanguard group	1.24M	0.00%	193.08K
Cooperman leon g	1.63M	0.33%	113.26K
Goldman sachs group	68.95K	0.00%	68.95K
Millennium management	84.83K	0.00%	51.14K

Top Sellers

Holder	Shares	% Assets	Change
Aristides capital	-	-	-106.33K
683 capital management	-	-	-76.12K
Bank of new york mellon	-	-	-24.00K
Ubs group	1.77K	-	-10.97K
Point72 asia (singapore) pte.	-	-	-9.50K

New Positions

Holder	Shares	% Assets	Change	Value
Goldman sachs group	68.95K	0.00%	68.95K	$374.39K
Barclays	27.73K	-	27.73K	$151.00K
Meridian wealth management	27.22K	0.01%	27.22K	$147.78K
Schonfeld strategic advisors	26.10K	0.00%	26.10K	$141.71K
Omers administration	22.50K	0.00%	22.50K	$122.17K

Sold Out

Holder	Change
Toronto dominion bank	-24.00
Jpmorgan chase	-27.00
Wells fargo & company/mn	-175.00
Federation des caisses desjardins du quebec	-230.00
Legend financial advisors	-1.00K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2025	60	27.66%	7,514,092	11.67%	17	7.08%	35	25.00%	10	100.00%
Dec 31, 2024	47	11.90%	6,729,012	20.58%	15	9.24%	28	27.27%	5	-16.67%
Sep 30, 2024	42	23.53%	5,580,411	10.22%	13	7.34%	22	83.33%	6	-33.33%
Jun 30, 2024	34	-	5,063,143	10.09%	13	6.69%	12	50.00%	9	12.50%
Mar 31, 2024	34	-15.00%	4,599,129	19.69%	14	13.77%	8	-55.56%	8	100.00%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	857.67K	2.00%	-
Vanguard US Total Market Shares ETF	747.20K	1.74%	-
iShares Russell 2000 ETF	473.59K	1.11%	3.28K
Vanguard Institutional Extnd Mkt Idx Tr	445.70K	1.04%	-
iShares Russell 2000 Growth ETF	215.78K	0.50%	532.00
Fidelity Extended Market Index	142.32K	0.33%	-636.00
State St Russell Sm Cap® Indx SL Cl I	92.50K	0.22%	92.50K
Jacob Discovery Fd Instl	89.73K	0.21%	-9.00K
Schwab Small Cap Index	66.30K	0.15%	66.30K
NT R2000 Index Fund - NL	63.88K	0.15%	63.88K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jul 23, 2025	STAHLBERG JAN	-	Buy	$5.40M
Jul 23, 2025	Von Koch Thomas	-	Buy	$10.00M
Jul 23, 2025	JACINTO RICHARD II	-	Buy	$1.40M
Jun 28, 2024	Von Koch Thomas	-	Buy	$3.00M
Jun 28, 2024	STAHLBERG JAN	-	Buy	$3.00M

Insider Transactions Trends

Date	Buy	Sell
2025 Q3	3	-
2025 Q2	-	-
2025 Q1	-	-
2024 Q2	2	-
2024 Q1	-	-

DMAC Ownership FAQ

Who Owns DiaMedica Therapeutics?

DiaMedica Therapeutics shareholders are primarily institutional investors at 17.54%, followed by 15.65% insiders and 66.81% retail investors. The average institutional ownership in DiaMedica Therapeutics's industry, Biotech Stocks , is 63.94%, which DiaMedica Therapeutics falls below.

Who owns the most shares of DiaMedica Therapeutics?

DiaMedica Therapeutics’s largest shareholders are Cooperman leon g (1.62M shares, 3.80%), Vanguard group (1.24M shares, 2.91%), and First manhattan co. llc. (839.08K shares, 1.96%). Together, they hold 8.67% of DiaMedica Therapeutics’s total shares outstanding.

Does Blackrock own DiaMedica Therapeutics?

Yes, BlackRock owns 0.28% of DiaMedica Therapeutics, totaling 105.3K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 310.64K$. In the last quarter, BlackRock increased its holdings by 1.93K shares, a 1.87% change.

Who is DiaMedica Therapeutics’s biggest shareholder by percentage of total assets invested?

Paragon associates & paragon associates ii joint venture is DiaMedica Therapeutics’s biggest shareholder by percentage of total assets invested, with 6.46% of its assets in 514.78K DiaMedica Therapeutics shares, valued at 2.8M$.

Who is the top mutual fund holder of DiaMedica Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of DiaMedica Therapeutics shares, with 2.00% of its total shares outstanding invested in 857.67K DiaMedica Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools